Quality of Life After Heart Transplantation

Nov 3, 2017 by in CARDIOLOGY Comments Off on Quality of Life After Heart Transplantation

© Springer International Publishing AG 2017Jon Kobashigawa (ed.)Clinical Guide to Heart Transplantation10.1007/978-3-319-43773-6_14 14. Quality of Life After Heart Transplantation Jon Kobashigawa1, 2   and Michael Olymbios3   (1) Director, Advanced Heart Disease Section, Cedars-Sinai Heart Institute, Los Angeles,…

read more

The Sensitized Patient Awaiting Heart Transplantation

Nov 3, 2017 by in CARDIOLOGY Comments Off on The Sensitized Patient Awaiting Heart Transplantation

Fig. 6.1 CDC and flow methods for cross-matching and determination of circulating HLA alloantibodies Abbreviations: CDC Complement Dependent Cytotoxicity, AHG Anti-human Globulin (Reused with permission from Tinckam and Chandraker [29])…

read more

Managing Infections in Cardiac Transplantation

Nov 3, 2017 by in CARDIOLOGY Comments Off on Managing Infections in Cardiac Transplantation

Underlying medical conditions (see Chap. 3) Antibiotic/medication allergies, adverse reactions Chest radiograph (to look for infiltrates, granumolas, scarring) Dental assessment Social/sexual history; high-risk behaviors, intravenous drug use, sexually transmitted diseases…

read more

Overview of Transplantation Immunobiology

Nov 3, 2017 by in CARDIOLOGY Comments Off on Overview of Transplantation Immunobiology

Fig. 5.1 The HLA gene cluster is localized on chromosome 6. HLA class I genes (HLA-A, B, C) encode HLA class I heavy chain which pairs with non-polymorphic protein β2-microglobulin…

read more

Immunosuppression Strategies in Heart Transplantation

Nov 3, 2017 by in CARDIOLOGY Comments Off on Immunosuppression Strategies in Heart Transplantation

Fig. 10.1 Diagram of mechanisms of action of common immunosuppressants in heart transplant. Through various pathways, the drugs inhibit T-cell proliferation. Abbreviations: G1 (first growth phase), S (synthesis of DNA),…

read more
Get Clinical Tree app for offline access